SCHEMBL22019653

SCHEMBL22019653

Cc1ccc(-c2ccc3c(c2)c2ccccc2n3-c2cc(-c3ccncc3)c(-n3c4ccccc4c4cc(-c5ccc(C)cc5C)ccc43)cc2C#N)c(C)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.35
ALDH1A1 P00352 3/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
LMNA P02545 2/20 0.35
NPSR1 Q6W5P4 2/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
MAPT P10636 1/20 0.35
RECQL P46063 1/20 0.35
SQOR Q9Y6N5 1/20 0.34
XDH P47989 1/20 0.34
GLA P06280 1/20 0.34
GAA P10253 1/20 0.34
HTT P42858 1/20 0.34
CYP2C19 P33261 2/20 0.33
PDE5A O76074 1/20 0.33
HPGD P15428 1/20 0.33
TSHR P16473 1/20 0.33
PTGS1 P23219 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19913110 0.96 MEN1 (0.38) KDM4EALDH1A1MEN1KMT2ALMNA
SCHEMBL19913112 0.95 KDM4E (0.33) KDM4EALDH1A1MEN1KMT2ALMNA
SCHEMBL22170307 0.94 XDH (0.36) KDM4EALDH1A1MEN1KMT2ALMNA
SCHEMBL19913124 0.94 ALDH1A1 (0.35) KDM4EALDH1A1MEN1KMT2ALMNA
SCHEMBL20923155 0.93 NPSR1 (0.36) KDM4EALDH1A1MEN1KMT2ALMNA
SCHEMBL20923596 0.93 ALDH1A1 (0.38) KDM4EALDH1A1MEN1KMT2ALMNA
SCHEMBL20923594 0.91 XDH (0.35) KDM4EALDH1A1MEN1KMT2ALMNA
SCHEMBL20923150 0.91 KDM4E (0.33) KDM4EALDH1A1MEN1KMT2ALMNA
SCHEMBL19913108 0.91 AR (0.40) KDM4EALDH1A1LMNANPSR1SQOR
SCHEMBL19908934 0.91 ALDH1A1 (0.43) KDM4EALDH1A1MEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11588114-B2 Organic molecules for use in optoelectronic devices SAMSUNG DISPLAY CO., LTD. (KR) 2023-02-21 US disclosed
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2020-07-02 US disclosed
US-10665792-B2 Organic molecules for use in optoelectronic devices CYNORA GMBH (DE) 2020-05-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES OR10J3, OPRM1, OR51E2 KDM4E 4526/4885ALDH1A1 297/4885MEN1 3205/4885
US-10665792-B2 Organic molecules for use in optoelectronic devices OR10J3, CFD, AOX1 KDM4E 3845/4885ALDH1A1 882/4885MEN1 2554/4885
US-11588114-B2 Organic molecules for use in optoelectronic devices OR10J3, OPRM1, OR51E2 KDM4E 4526/4885ALDH1A1 297/4885MEN1 3205/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.